butylscopolammonium bromide has been researched along with Laryngeal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azuara, ML; Barcia, E; Negro, S; Reyes, R; Sánchez, Y | 1 |
1 other study(ies) available for butylscopolammonium bromide and Laryngeal Neoplasms
Article | Year |
---|---|
Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Butylscopolammonium Bromide; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Drug Combinations; Drug Stability; Drug Storage; Female; Haloperidol; Humans; Injections, Subcutaneous; Laryngeal Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Morphine; Muscarinic Antagonists; Palliative Care; Retrospective Studies; Time Factors | 2006 |